Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4312 results

Sort By:

Actinium Therapy for Late-stage Aggressive Sarcomas

Study ID: NCT07156565
Start Date: 2025-10
End Date: 2032-01
Study Type

Interventional

Study Phase

Phase1

No. of Participants

26

Intervention / Treatment

[Ac 225]RTX-2358

[Cu64]LNTH-1363S

Sponsor

Ratio Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Virtual Reality in Intensive Care Unit: Patient Satisfaction, Clinical and Functional Outcomes, Feasibility

Study ID: NCT07089134
Start Date: 2025-12-15
End Date: 2026-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

90

Intervention / Treatment

Traditional Physiotherapeutic Rehabilitation

Physiotherapy using immersive virtual reality

Sponsor

Syrian hospital-libanes

Source: clinicaltrials.gov

Share:
Add to list

Safety and Feasibility of Using Cerebrolysin in the Treatment of Primary Intracerebral Hemorrhage - a Prospective Randomized Open Blinded End-point Trial

Study ID: NCT06899464
Start Date: 2025-10-01
End Date: 2027-04-01
Study Type

Interventional

Study Phase

Phase4

No. of Participants

30

Intervention / Treatment

14-day Cerebrolysin treatment

Standard of Care (SOC)

Sponsor

Cardinal Stefan Wyszynski University

Source: clinicaltrials.gov

Share:
Add to list

3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis

Study ID: NCT06903884
Start Date: 2025-12-30
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

94

Intervention / Treatment

3% Diquafosol ophthalmic solution and 0.1% Cyclosporin A cationic ophthalmic emulsion

0.1% Cyclosporin A cationic ophthalmic emulsion

Sponsor

The University of Hong Kong

Source: clinicaltrials.gov

Share:
Add to list

A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Study ID: NCT06066138
Start Date: 2025-09-30
End Date: 2027-01-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

40

Intervention / Treatment

Atezolizumab

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Efficacy of a Wearable Noninvasive Neuromodulation Device

Study ID: NCT07171489
Start Date: 2025-11
End Date: 2029-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

TNM at a sham-point (AccelBand) - randomized arm

TNM at a leg point (AccelBand)- randomized arm

TNM at a leg point (AccelBand)- open-label

Sponsor

University of Michigan

Source: clinicaltrials.gov

Share:
Add to list

Inspiratory Muscle Training in Amateur CrossFit® Athletes

Study ID: NCT06807957
Start Date: 2025-10-25
End Date: 2026-03-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

94

Intervention / Treatment

Group with IMT

CrossFit® Training

Sponsor

Federal University of the valleys of jekiitinhonha and mucuri

Source: clinicaltrials.gov

Share:
Add to list

Phase II Study of CD5 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Aggressive T Cell Hematological Malignancies

Study ID: NCT07137481
Start Date: 2026-02-28
End Date: 2032-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

70

Intervention / Treatment

C9/CD5CAR/IL-15 NK cells

Rituximab

Fludarabine

Cyclophosphamide

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Treatment Effects on Gait in Hammertoe Patients

Study ID: NCT07166016
Start Date: 2025-10-01
End Date: 2027-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Conservative

Surgical

Sponsor

University of Texas Rio Grande Valley

Source: clinicaltrials.gov

Share:
Add to list

Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells

Study ID: NCT06930976
Start Date: 2025-10-01
End Date: 2027-06-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

12

Intervention / Treatment

13C6-Glucose

Sponsor

Vanderbilt University Medical Center

Source: clinicaltrials.gov

Share:
Add to list